BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9859824)

  • 1. Retrospective analysis of the prognostic significance of DNA ploidy patterns in gastric cancer.
    Tirindelli Danesi D; Cucchiara G; Picconi A; Daffinà M; Fabiano A; Antonini F; Toscano MG; Pasqualetti P; Altavista P; Cordelli E; Spanò M
    Eur J Histochem; 1997; 41 Suppl 2():147-8. PubMed ID: 9859824
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer.
    Victorzon M; Roberts PJ; Haglund C; von Boguslawsky K; Nordling S
    Anticancer Res; 1997; 17(4B):2923-6. PubMed ID: 9329565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric carcinoma: recent issues in prognostic factors.
    Chen BF; Marrogi AJ; Freeman SM; Clejan S
    J La State Med Soc; 1995 Apr; 147(4):138-45. PubMed ID: 7775839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA ploidy pattern and p53 overexpression in gastric cancer].
    Tomisaki S; Tatsuo O; Hisao O; Sakaguchi Y; Kusumoto T; Ohno S; Ichiyoshi Y; Maehara Y; Sugimachi K
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():115-7. PubMed ID: 7611772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.
    Lee KH; Lee JS; Lee JH; Kim SW; Suh C; Kim WK; Kim SH; Min YI; Kim BS; Park KC; Lee MS; Sun HS
    Br J Cancer; 1999 Apr; 79(11-12):1727-35. PubMed ID: 10206284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of DNA ploidy, c-erB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
    Takamura H; Yonemura Y; Fonseca L; Ninomiya I; Tsugawa K; Miwa K; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1995 Apr; 96(4):213-22. PubMed ID: 7753016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
    Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
    Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy, S phase fraction and telomerase activity in gastric cancer.
    Caldini A; Gelmini S; Rapi S; Amorosi A; Bruno L; Nesi G; Bartolini L; Pazzagli M; Orlando C
    Eur J Histochem; 1997; 41 Suppl 2():123-4. PubMed ID: 9859812
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis.
    Esteban F; de Vega DS; Garcia R; Rodriguez R; Manzanares J; Almeida A; Tamames S
    Hepatogastroenterology; 1999; 46(27):2039-43. PubMed ID: 10430394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
    Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
    J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy and S-phase fraction as prognostic factors in surgically resected gastric carcinoma: a 7-year prospective study.
    Nesi G; Bruno L; Saieva C; Caldini A; Girardi LR; Zanna I; Rapi S; Bechi P; Cortesini C; Palli D
    Anticancer Res; 2007; 27(6C):4435-41. PubMed ID: 18214057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
    Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
    Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy patterns in advanced gastric carcinoma; is it a clinically applicable prognosticator?
    Lee JH; Noh SH; Lee KY; Choi SH; Min JS
    Hepatogastroenterology; 2001; 48(42):1793-6. PubMed ID: 11813626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
    Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
    J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in submucosal carcinoma of the esophagus.
    Kimura H; Konishi K; Maeda K; Yabushita K; Kuroda Y; Tsuji M; Miwa A
    Hepatogastroenterology; 1999; 46(25):285-9. PubMed ID: 10228808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions as predictors of survival in surgically resected gastric cancer patients.
    Danesi DT; Spanò M; Fabiano A; Altavista P; Pasqualetti P; Toscano MG; Antonini F; Catalano P; Mecozzi A; Picconi A; Daffinà A; Cucchiara G
    Cytometry; 2000 Feb; 42(1):27-34. PubMed ID: 10679740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.